ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 674278 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 674278; 2) Community: the network communities that were significantly associated with the response to NSC 674278; 3) Molecule: the relationships between components within communities and NSC 674278; 4) MDR: the compounds that were significantly associated with the NSC 674278.

NSC Compound Enrichment Correlation
NSC 724784 (1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 0.0135712240673827 -0.35891008
NSC 174121 Methotrexate Derivative 0.0135712240673828 -0.34200465
NSC 191924 Null 0.0135712240673828 -0.21189007
NSC 271674 Carboxyphthalatoplatinum 0.0135712240673828 -0.27759696
NSC 285166 Oxine 0.0135712240673828 -0.39910706
NSC 30637 Null 0.0135712240673828 -0.24573148
NSC 376266 1-Piperazinethiocarboxylic acid, 4-(2-propynyl)- 2-[1-(2-pyridinyl)ethylidene]hydrazide 0.0135712240673828 -0.35770512
NSC 620462 Null 0.0135712240673828 -0.28671724
NSC 631197 9-N-(N'-chloroethyl-N'-ethyl-1,4-diamino-butyl)2-methoxy acridine dihydrochloride 0.0135712240673828 -0.26668009
NSC 632129 (E)-1-(2,5-Dihydroxyphenyl)ethene-2-isonitrile 0.0135712240673828 -0.34180783
Total:152  Current:66    [First] [Prev] [Next] [Last]